NCT06342284Recruiting
Patient-Generated Health Data Collection During Chemoradiotherapy for Lung Cancer
Patient-Generated Health Data Collection During Chemoradiotherapy for Lung Cancer: A Pilot Study
Source: ClinicalTrials.gov · Last updated 13 Apr 2026
Brief summary (registry, in English)
This is an observational study involving the collection of patient-generated health data using an Apple Watch, a home pulse oximeter, and a smartphone during a course of proton beam radiotherapy for lung cancer. The study period over which this information is collected will range from the day of study enrollment until two weeks after radiotherapy completion. Subjects will complete a short satisfaction survey at the end of the study period. Other information that is collected as part of routine care for this patient population will be extracted from subjects' medical records during the study period and afterwards.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 40 (estimated)
- First submitted
- 20 Mar 2024
- Start date
- 22 Mar 2024
- Primary completion date
- Mar 2028
- Lead sponsor
- The New York Proton Center
- Diseases
- Lung cancer
- NCT number
- NCT06342284
What you commit to
- Study type: Observational
- Planned participants: 40
- From 22 Mar 2024 to the primary completion date, Mar 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Ongoing treatment for another cancer that is expected to affect the toxicity profile of thoracic radiotherapy
Other
- Pregnancy or women of childbearing potential and men who are sexually active and not willing/able to use medically acceptable forms of contraception; this exclusion is necessary because the treatment involved in this study may be significantly teratogenic
Who the study is looking for
- Plan for fractionated (≥15 treatments) proton beam thoracic radiotherapy with curative intent for lung cancer
- Non-small cell lung cancer (NSCLC) or small cell lung cancer (SCLC) histology is permitted.
- Concurrent chemotherapy is permitted but not required..
- Previous thoracic radiotherapy is allowed.
- Ability to complete study surveys in English or Spanish
- Age \>/= 18
- Concurrent enrollment on other trials is permitted
- Patients who already use wearable devices and/or smartphones that monitor physical activity are eligible for this trial, provided they agree to utilize the devices provided by the study team during the study period
- All patients must sign study-specific informed consent prior to study entry
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| New York Proton Center Coordinator of this site? Confirm its status | New York | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.